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Toll-like receptors (TLRs) play an important role in
antiviral response by recognizing viral components.
Recently, a RNA helicase, RIG-I, was also suggested
to recognize viral double-stranded RNA. However,
how these molecules contribute to viral recognition
in vivo is poorly understood. We show by gene tar-
geting that RIG-I is essential for induction of type I
interferons (IFNs) after infection with RNA viruses in
fibroblasts and conventional dendritic cells (DCs).
RIG-I induces type I IFNs by activating IRF3 via IB
kinase-related kinases. In contrast, plasmacytoid
DCs, which produce large amounts of IFN-, use the
TLR system rather than RIG-I for viral detection.
Taken together, RIG-I and the TLR system exert antivi-
ral responses in a cell type-specific manner.
Introduction
The invasion of viruses is initially sensed by the host
innate immune system that provokes antiviral immune
responses. Antiviral host defense is mediated by the*Correspondence: sakira@biken.osaka-u.ac.jprapid induction of type I interferons (IFNs) and proin-
flammatory cytokines, leading to subsequent activation
of adaptive immune responses (Biron, 1999; Le Bon
and Tough, 2002). Type I IFNs are produced by various
types of cells after viral infection. Dendritic cells (DCs)
secrete large amounts of type I IFNs in response to
viruses. Among recently identified subsets of DCs,
plasmacytoid DCs (pDCs) are characterized for their
potent ability to secrete IFN-α (Cella et al., 1999; Co-
lonna et al., 2002). Conventional DCs (cDCs), however,
can act as specialized IFN-producing cells in a certain
viral infections (Diebold et al., 2003). In addition, non-
professional immune cells such as fibroblasts also pro-
duce IFN-β in response to viral infection.
Recent studies revealed that Toll-like receptors
(TLRs) are critical for the recognition of pathogen-spe-
cific molecular patterns (PAMPs) derived from both
bacterial and viral species (Akira and Takeda, 2004;
Beutler, 2004; Medzhitov, 2001). Among 11 reported
TLRs, TLR3, TLR4, TLR7, TLR8, and TLR9 are involved
in the recognition of viral components. In mice, viral
double-stranded (ds) RNA, fusion protein of respiratory
syncytial virus, single-stranded (ss) RNA, and genomic
DNA from herpes species and murine cytomegalovirus
are recognized by TLR3, TLR4, TLR7, and TLR9, re-
spectively (Alexopoulou et al., 2001; Kurt-Jones et al.,
2000; Heil et al., 2004; Diebold et al., 2004; Lund et al.,
2003, 2004; Krug et al., 2004a, 2004b). Stimulation with
TLR3 and TLR4 ligands results in the activation of two
IκB kinase (IKK)-related kinases, IKK-i, also called IKK,
and TANK binding kinase-1 (TBK1), also named as T2K,
which are responsible for the phosphorylation of IFN-
regulatory factor 3 (IRF3) (Fitzgerald et al., 2003;
Sharma et al., 2003; McWhirter et al., 2004). Phosphory-
lated IRF3 dimerizes and translocates into the nucleus
for the transcription of IFN-β (Yoneyama et al., 1998). In
contrast, MyD88 can directly associate with IRF7,
which is responsible for the induction of IFN-α after
TLR9 ligand stimulation (Kawai et al., 2004). IRAK1 is
also involved in IFN-α production by phosphorylating
IRF-7 (Uematsu et al., 2005). Stimulation with TLR li-
gands also activates a transcription factor, NF-κB,
which is responsible for the induction of proinflamma-
tory cytokines.
We have previously shown that a cytoplasmic pro-
tein, retinoic-acid inducible gene-I (RIG-I), can recog-
nize viral dsRNA to induce the type I IFN response
in vitro (Yoneyama et al., 2004). RIG-I contains an
N-terminal caspase recruitment domain (CARD) and a
C-terminal DExD/H box RNA helicase domain (Yone-
yama et al., 2004; Sun, 1997). The helicase domain is
responsible for dsRNA recognition, and the CARD do-
main activates downstream signaling pathways. How-
ever, functional role of RIG-I in vivo has not been clari-
fied yet. Furthermore, the relationship between RIG-I
and TLRs in the recognition of viruses is unclear.
In this study, we generated RIG-I-deficient mice and
showed that RIG-I, but not the TLR system, plays an
essential role in antiviral responses in various cells ex-
cept pDCs. Reciprocally, the TLR system, but not
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20Figure 1. Targeted Disruption of the Murine RIG-I Gene
(A) Structure of the mouse RIG-I gene, the targeting vector, and the predicted disrupted gene. Closed boxes denote the coding exon. E,
EcoRV; DECH, DExD/H box.
(B) Southern blot analysis of offspring from the heterozygote intercrosses. Genomic DNA was extracted from mouse tails, digested with
EcoRV, separated by electrophoresis, and hybridized with the radiolabeled probe indicated in (A). Southern blot gave a single 9.3 kb band
for wild-type (+/+), a 7.2 kb band for homozygous (−/−), and both bands for heterozygous (+/−) mice.
(C) Nothern blot analysis of MEFs. Total RNA from wild-type (WT) and RIG-I−/− MEFs transfected with 10 g/ml poly (I:C) for the indicated
periods was extracted and subjected to the Northern blot analysis for the expression of RIG-I mRNA. The same membrane was rehybridized
with an Actb (β-actin) probe.
(D) Western blot analysis of RIG-I expression in WT and RIG-I−/− MEFs transfected with 10 g/ml poly (I:C) for 8 hr. Whole-cell lysates were
immunoblotted with antibody to RIG-I. The same membrane was blotted again with antibody to ERK1/2.
(E) Genotype analysis of neonatal offspring or embryos at d12.5–d13.0 or d13.5–d14.0 from the heterozygote intercrosses.
(F) Hematoxylin and eosin staining of transverse sections through the fetal liver of WT and RIG-I−/− embryos at d12.5.
(G) Genotype analysis of neonatal offspring from intercrossing TNF-α−/− RIG-I+/− mice.RIG-I, is indispensable to IFN-α secretion in pDCs. T
sThus, induction of type I IFNs in RNA virus infection
would be triggered by either RIG-I or the TLR system i
sin a cell type-specific manner.
Results G
R
rThe TLR System Is Dispensable for Viral
Recognition in Fibroblasts i
wAll known TLRs have been shown to signal through Toll/
IL-1R homology (TIR) domain-containing adaptor mole- o
Ecules, MyD88, and/or TIR domain-containing adaptor-
inducing IFN-β (TRIF). Mice deficient in both MyD88 i
Rand TRIF (MyD88−/−TRIF−/−) are unresponsive to stimu-
lation with all known TLR ligands (Yamamoto et al., 1
l2003). To examine the role of TLR signaling pathways
in the recognition of RNA viruses in fibroblasts, we first w
binfected MyD88−/−TRIF−/− mouse embryonic fibroblasts
(MEFs) with Newcastle disease virus (NDV) and ana- g
tlyzed upregulation of IFN-β and IFN-inducible genes.
NDV infection induced IFN-β and IFN-inducible genes l
erepresented by IP-10 and RANTES, as well as IL-6 in
MyD88−/−TRIF−/− MEFs to the same extent as wild-type I
cells (Figure 2A). Moreover, MEFs deficient in eitherLR3, TLR7, or TLR9 displayed similar results (data not
hown), indicating that the antiviral response in MEFs
s mediated by mechanism independent of the TLR
ystem.
eneration of RIG-I-Deficient Mice
ecently identified RIG-I is also implicated in antiviral
esponses. However, the functional role of RIG-I in vivo
s still unclear. To investigate the role of RIG-I in vivo,
e generated RIG-I-deficient (RIG-I−/−) mice by homol-
gous recombination of ES cells (Figures 1A and 1B).
xpression of RIG-I mRNA and protein was abrogated
n RIG-I−/− cells (Figures 1C and 1D). Although most
IG-I−/− embryos were lethal at embryonic days 12.5 to
4.0, a few mice were born alive (Figure 1E). Neverthe-
ess, these mice showed growth retardation and died
ithin 3 weeks after birth. Histological analysis of em-
ryonic day 12.5 embryos revealed massive liver de-
eneration (Figure 1F). A TUNEL assay revealed that
he aberrant occurrence of apoptosis in the embryonic
iver can explain the developmental defect of RIG-I−/−
mbryos (data not shown). Mice lacking either RelA,
KK-β, or TBK1 are also reported to be embryonic lethalbecause of liver apoptosis. In embryogenesis, these
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21Figure 2. Abolished Responses to RNA Virus
Infection in RIG-I−/− Fibroblasts
(A) WT, MyD88−/−TRIF−/− (left), and RIG-I−/−
(right) MEFs were infected with NDV for the
indicated periods. Total RNA was extracted
and subjected to the Northern blot analysis
for the expression of Ifnb (IFN-β), Cxcl10
(IP-10), Ccl5 (RANTES), Il6 (IL-6), and Actb
(β-actin).
(B and C) WT and RIG-I−/− MEFs were in-
fected with VSV (moi = 0.2) ([B], left), SV
(moi = 20) ([B], right), or stimulated with 10
g/ml LPS (C) for the indicated periods (Ifit2:
ISG54). Northern blot analysis was per-
formed using the indicated probes.
(D) Lung fibroblasts from WT and RIG-I−/−
mice were infected with SV (moi = 20) for the
indicated periods. Northern blot analysis
was performed using the indicated probes.through its helicase domain. Therefore, we first exam- presses GFP in infected cells, RIG-I cells have re-
Figure 3. A Critical Role of RIG-I in Eliminat-
ing Viral Infection
(A) WT and RIG-I−/− MEFs pretreated with or
without IFN-β were infected with VSV at
moi = 0.1 for 24 hr. Cells and expression of
GFP were visualized by a confocal micros-
copy.
(B) WT and RIG-I−/− MEFs were infected with
the indicated moi of VSV. Virus yield in the
supernatants after VSV infection was deter-
mined by plaque assay. Data are representa-
tive of three independent experiments. Indi-
cated values are means + SD of triplicates.
pfu, plaque-forming unit.molecules are supposed to inhibit TNF-induced cell
death, as evidenced by the rescue of developmental
defect under TNFR deficiency (Doi et al., 1999; Li et al.,
1999; Bonnard et al., 2000). Therefore, we hypothesized
that the liver apoptosis of RIG-I−/− mice is also due to
altered TNF signaling. Therefore, we tried to generate
TNF-α−/−RIG-I−/− mice. However, we could obtain only
1 RIG-I−/−TNF-α−/− mouse out of 43 pups born from in-
tercrossing RIG-I+/−TNF-α−/− mice (Figure 1G), indicat-
ing that TNF-α deficiency failed to rescue the embry-
onic lethality of RIG-I−/− mice. These results indicate
that the developmental defect of RIG-I−/− mice might
be caused by a mechanism(s) independent of TNF-α
signaling.
Essential Role of RIG-I in Viral Recognition
in Fibroblsts
RIG-I is involved in the recognition of viral dsRNAined the expression of IFN-β and IFN-inducible genes
in MEFs after infection with several RNA viruses. The
induction of IFN-β, IFN-inducible genes, and IL-6 in re-
sponse to NDV was abrogated in RIG-I−/− MEFs (Figure
2A). In addition, infection with several other RNA
viruses, including vesicular stomatitis virus (VSV) and
Sendai virus (SV), also failed to upregulate IFN-β as well
as IFN-inducible genes in RIG-I−/− cells (Figure 2B). In
contrast, stimulation with lipopolysaccharide (LPS), a
TLR4 ligand, induced the expression of IP-10 and IL-6
genes in both wild-type and RIG−/− cells (Figure 2C).
Moreover, lung fibroblasts from RIG-I−/− mice did not
upregulate IFN-β and IFN-inducible genes after SV in-
fection (Figure 2D), indicating that RIG-I is essential for
the induction of IFN response upon viral infection in
nonprofessional immune cells like fibroblasts.
Next, we analyzed the contribution of RIG-I to antivi-
ral effect. When MEFs were infected with VSV that ex-
−/−
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22Figure 4. Activation of Signaling Cascade in RIG-I−/− Fibroblasts
(A) WT and RIG-I−/− MEFs were infected with NDV for the indicated periods. Cell lysates were prepared and subjected to native PAGE.
Monomeric (arrow) and dimeric (arrowhead) forms of IRF3 were detected by Western blotting.
(B) The cell extracts used in (A) were probed for phospho-STAT1 and total STAT1.
(C and D) WT and RIG-I−/− MEFs were stimulated with 10 g/ml LPS or infected with NDV for the indicated periods. Nuclear extracts were
prepared, and ISRE (C) and NF-κB (D) DNA binding activity was determined by EMSA. The arrowhead indicates the induced band of ISRE or
NF-κB complex. N.S., nonspecific bands.
(E) WT, RIG-I−/−, and TBK1−/−IKK-i−/− MEFs were transiently transfected with a reporter construct containing the IFN-β promoter together with
the indicated expression vectors. Transfected cells were infected with SV (moi = 20) and were subjected to the luciferase assay. Error bars
show the SD of two independent experiments.VSV-induced IFN-β mRNA expression was abrogated in cells was increased about 100-fold compared with that
Figure 5. Abolished Responses to NDV Infection in RIG-I−/− cDCs
(A and B) GM-CSF-DCs used as cDCs from WT, RIG-I−/−, and MyD88−/−TRIF−/−mice were infected with NDV for the indicated periods. Total
RNA was extracted and supernatants were harvested. IFN-β (A) and IL-6 (B) mRNA levels were determined by Q-PCR. N.D., not detected.
(C) GM-CSF-DCs used as cDCs from WT, RIG-I−/−, and MyD88−/−TRIF−/−mice were infected with increasing doses of NDV for 24 hr. IFN-α
production in the supernatants was measured by ELISA. Data are shown as mean ± SD of triplicate samples of a representative from three
independent experiments.markably increased GFP-positive cells compared to R
rwild-type cells (Figure 3A). However, priming of RIG-
I−/− cells with IFN-β clearly decreased the number of o
minfected cells in response to VSV infection. Given thatIG-I−/− cells (Figure 2B), RIG-I may mediate antiviral
esponse via induction of type I IFNs (Figure 3A). More-
ver, when MEFs were infected with VSV at various
ultiplicities of infection (moi), viral yield of RIG-I−/−
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23of wild-type cells (Figure 3B). These results demon-
strate that RIG-I plays a critical role in eliminating viral
infection through induction of IFN response.
Signaling Pathway Activated by Viral Infection
Induction of type I IFNs and proinflammatory cytokines
requires activation of transcription factors IRF3 and NF-
κB (Sato et al., 2000; Taniguchi and Takaoka, 2002).
IRF3 is phosphorylated by TBK1 and IKK-i. The phos-
phorylated IRF3 induces the expression of the IFN-β
gene. The produced of IFN-β subsequently stimulates
the JAK-STAT pathway to amplify the responses (Shuai
and Liu, 2003). To determine the role of RIG-I in the
activation of signaling pathways, we analyzed activa-
tion of IRF3 after NDV infection in RIG-I−/− MEFs. NDV-
induced dimerization of IRF3, as well as phosphoryla-
tion of STAT1, was abrogated in RIG−/− MEFs (Figures
4A and 4B). Furthermore, electrophoretic mobility shift
assay (EMSA) revealed that activation of IFN stimulated
a regulatory element (ISRE), and NF-κB was also abro-
gated in RIG-I−/− cells in response to NDV infection, but
not to LPS stimulation (Figures 4C and 4D). These re-
sults demonstrate that RIG-I is essential for activating
transcription factors initially activated after viral infec-
tion. The IFN-β-dependent reporter gene expression
was induced in response to SV infection in wild-type
MEFs (Figure 4E). In contrast, SV infection failed to acti-
vate the reporter gene in RIG-I−/− or IKK-i−/−TBK1−/−
cells. The ectopic expression of RIG-I gene restored
SV-induced IFN-β promoter activity in RIG-I−/− cells, but
not in IKK-i−/−TBK1−/− cells. Overexpression of both
TBK1 and IKK-i in RIG-I−/− cells activated the IFN-β pro-
moter (Figure 4E), indicating that RIG-I induces type I
IFNs via IKK-i/TBK1.
Differential Requirement of the TLR System
and RIG-I in IFN- Production in pDCs and cDCs
DCs play an important role in detecting pathogens and
activating T cells by presenting antigens, producing
cytokines and type I IFNs (Kaisho and Akira, 2003;
Trinchieri, 2003; Malmgaard, 2004). DCs are roughly
subdivided into two different subsets; conventional
DCs (cDCs) and plasmacytoid DCs (pDCs) (Cella et al.,
1999; Colonna et al., 2002; Diebold et al., 2003; Malm-
gaard, 2004). Recent studies demonstrated that pDCs
secrete large amounts of IFN-α upon viral exposure
(Cella et al., 1999; Colonna et al., 2002; Diebold et al.,
2003). Therefore, we examined the IFN response of
RIG-I−/− DCs after viral infection. First, we tested cDCs
induced from bone marrow (BM) in the presence of GM-
CSF. The induction of CD11c+ DCs was not impaired in
RIG-I−/− BM cells cultured with GM-CSF (see Figure
S1A in the Supplemental Data available with this article
online). Real-time PCR analysis revealed that NDV in-
fection induced the expression of IFN-β in cDCs from
wild-type mice as well as those from MyD88−/−TRIF−/−
mice (Figure 5A). In contrast, cDCs from RIG-I−/− mice
showed severely impaired IFN-β induction after NDV in-
fection. NDV-induced IL-6 production was also severely
impaired in RIG-I−/−, but not in MyD88−/−TRIF−/− cDCs
(Figure 5B). Next we examined the production of IFN-α
in NDV-infected cDCs by ELISA. As shown in Figure 5C,
production of IFN-α was severely impaired in cDCsfrom RIG-I−/−, but not MyD88−/−TRIF−/−, mice, indicating
that induction of both IFN-α and IFN-β is regulated by
RIG-I in cDCs.
Then we generated Flt3L-induced BM-derived DCs
(Flt3L-DCs), which contained pDCs, stimulated them
with NDV, and measured IFN-α production. The popula-
tion of pDCs obtained by culture with Flt3L from wild-
type and RIG-I−/− mice was not altered (Figure S1B).
Unexpectedly, Flt3L-DCs from RIG-I−/− mice produced
similar amounts of IFN-α and IL-6 as those from wild-
type mice (Figures 6A and 6B). On the other hand,
IFN-α and IL-6 production from MyD88−/−TRIF−/− Flt3L-
DCs as well as MyD88−/− Flt3L-DCs were severely im-
paired compared to those from wild-type Flt3L-DCs
(Figures 6A and 6B). Since cells obtained by Flt3L cul-
tures contained both cDCs (CD11c+B220−) and pDCs
(CD11c+B220+), we costained RIG-I−/− or MyD88−/−
FltL-DCs for IFN-α, CD11c, and B220 and analyzed
them by flow cytometry. As shown in Figure 6C, the
production of IFN-α in CD11c+B220+ pDCs was compa-
rable between wild-type and RIG-I−/− Flt3L-DCs, whereas
that from CD11c+B220− cells was severely impaired in
RIG-I−/− Flt3L DCs. In contrast, production of IFN-α in
pDCs was severely impaired in MyD88−/− mice (Figure
6D). IFN-α production in MyD88−/− cDCs was normal,
albeit the frequency of IFN-α-positive cells was lower
than that of pDCs. On the other hand, neither pDCs
nor cDCs from MyD88−/− mice responded to CpG-ODN
stimulation. To examine whether IFN-β is also regulated
by the TLR system, we purified pDCs from Flt3L-DCs,
infected them with NDV, and assessed the induction of
mRNA for IFNs and IL-6 by real-time PCR. As shown in
Figure 6C, the induction of mRNA for IFN-β, IFN-α4,
IFN-α6/8, and IL-6 was severely impaired in MyD88−/−
pDCs, indicating that induction of both IFN-α and IFN-β
is mainly regulated by MyD88 in pDCs. These results
indicate that the TLR system rather than RIG-I is a pre-
requisite for the recognition of viruses to induce type I
IFNs in pDCs. Since pDCs highly express TLR7 (Heil et
al., 2004; Diebold et al., 2004) and TLR9 (Lund et al.,
2003; Krug et al., 2004a), we analyzed Flt3L-DCs from
either TLR7−/− or TLR9−/− mice for NDV responsiveness.
Wild-type Flt3L-DCs produced IFN-α in a dose- and
time-dependent manner (Figures 6A and 6B). In con-
trast, TLR7−/− Flt3L-DCs showed impaired IFN-α pro-
duction in response to NDV infection (Figures 6A and
6B). TLR9−/− Flt3L-pDCs also showed impaired IFN-α
production to a lesser extent compared to TLR7−/− cells
(Figures 6A and 6B). These results indicate that TLR7
and TLR9 are involved in NDV recognition in pDCs.
We further investigate the role of RIG-I in cDCs and
pDCs directly purified from mouse spleens. The com-
position of splenic cDCs and pDCs was not altered be-
tween wild-type and RIG-I−/− mice (Figure S1C). We
purified CD11chighmPDCA1− cDCs and CD11c+mPDCA1+
pDCs from splenocytes from wild-type, MyD88−/−, or
RIG-I−/− mice by FACS sorting. Infection with NDV in-
duced the production of IFN-α in both pDCs and cDCs
from wild-type mice (Figure 7). In contrast, pDCs, but
not cDCs, from MyD88−/− mice showed severely im-
paired production of IFN-α in response to NDV infection
(Figure 7A). Reciprocally, the IFN-α response was de-
fective in RIG-I−/− splenic cDCs (Figure 7B), although
pDCs from wild-type and RIG-I−/− mice secreted com-
Immunity
24Figure 6. The TLR System, Rather than RIG-I, Is a Prerequisite for the Recognition of NDV to Induce IFN-α and IL-6 in pDCs
(A) Flt3L-DCs from WT, MyD88−/−, TLR7−/−, TLR9−/−, MyD88−/−TRIF−/−, and RIG-I−/− mice were infected with NDV or stimulated with 3 M CpG
DNA (D35). Production of IFN-α (left) and IL-6 (right) was measured by ELISA. Data are representative of three independent experiments.
Indicated values are means + SD of triplicates. N.D., not detected.
(B) Flt3L-DCs from WT, TLR7−/−, and TLR9−/− mice were infected with NDV for the indicated time, and IFN-α production was measured. Data
are shown as mean ± SD of triplicate samples of a representative from three independent experiments.
(C and D) Flt3L-DCs from RIG-I+/+ and RIG-I−/−(C) or MyD88+/− and MyD88−/− mice (D) were infected with NDV or stimulated with 2 M CpG
DNA (D19). Cells were fixed and subjected to intracellar IFN-α staining as described in Experimental Procedures. Induction of IFN-α in pDCs
and cDCs was separately analyzed based on the gates indicated.
(E) Purified CD11c+B220+ DCs were infected with NDV. Total RNA was harvested and IFN-β, IFN-α6/8, IFN-α4 and IL-6 mRNA levels were
measured by Q-PCR.parable amounts of IFN-α. Thus, these observations in- o
ddicate that cDCs and pDCs mainly exploit RIG-I and





We showed here that RIG-I was critical for RNA virus- F
mediated IFN response in fibroblasts and cDCs by gen- s
erating RIG-I−/− mice. Most RIG-I−/− mice were embry- R
onic lethal at embryonic days 12.5 to 14.0 because of a
liver degeneration, although a few mice overcame the T
developmental defect and were born alive. Genes re- t
lated to NF-κB activation in TNF-α signaling and TBK1, t
a kinase responsible for IRF-3 phosphorylation, are a
known to regulate the development of the liver. Al- e
though the mice deficient in either RelA, IKK-β, or TBK1 N
are embryonic lethal due to liver apoptosis, disruption m
of TNF-α signaling rescues the developmental defect. i
Therefore, we hypothesized that TNF signaling is also i
involved in the liver degeneration of RIG-I−/− embryos. i
However, TNF-α deficiency failed to rescue the embry-nic lethality of RIG-I−/− mice. Thus, a mechanism(s) in-
ependent of TNF-α signaling is responsible for the
iver degeneration of RIG-I−/− mice. Further studies are
equired to determine the cause of the developmental
efect in RIG-I−/− mice.
The responses to several single-stranded RNA viruses,
DV, VSV, and SV, were abrogated in RIG-I−/− MEFs.
urthermore, increased viral yield and the restored re-
istance to VSV infection by the IFN-β pretreatment in
IG-I−/− MEFs demonstrate that RIG-I exerts its antiviral
ctivity via inducing type I IFNs. In addition to RIG-I,
LR3, TLR4, TLR7, and TLR9 have been implicated in
he recognition of viruses. TLR3 and TLR4 activate TRIF
o induce type I IFNs (Yamamoto et al., 2003), and TLR7
nd TLR9 utilize MyD88 to activate type I IFNs (Hemmi
t al., 2002; Hoshino et al., 2002; Kawai et al., 2004).
evertheless, MEFs and cDCs from MyD88−/−TRIF−/−
ice displayed normal type I IFN induction upon NDV
nfection, indicating that the TLR system is not required
n these cells for the induction of type I IFNs after viral
nfection. TLRs are transmembrane proteins that local-
ize either on plasma membrane or in intracellular vesi-
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25T. Shioda (Osaka University). LPS from Salmonella minnesota Re-pDCs from RIG-I mice showed normal production of
Figure 7. Splenic pDCs Utilize the TLR System, and RIG-I Is Essential in Splenic cDCs for the Recognition of NDV to Induce IFN-α
(A) Splenic CD11c+mPDCA-1+ pDCs and CD11chighmPDCA-1− cDCs were purified from WT and MyD88−/− mice by FACS sorting. pDCs and
cDCs were infected with NDV for 24 hr, and IFN-α production from pDCs (1 × 104) or cDCs (1 × 104) was measured by ELISA.
(B) Splenic CD11c+mPDCA-1+ pDCs and CD11chighmPDCA-1− cDCs were purified from WT and RIG-I−/− mice by FACS sorting. pDCs and
4 4cles, indicating that TLRs can detect PAMPs in extra-
cellular or luminal spaces. On the other hand, RIG-I is a
cytoplasmic protein without a transmembrane domain.
These observations suggest that cytoplasmic detection
of infected viruses plays a main role in antiviral re-
sponses in MEFs and cDCs.
Protein kinase R (PKR) is also one of the sensors of
viral invasion (Williams, 2002). PKR is a cytosolic pro-
tein composed of dsRNA binding motifs and a serine/
threonine kinase domain. Binding of PKR with viral
dsRNA results in the phosphorylation of the translation
initiation factor, eIF2α, and translational inhibition (Wil-
liams, 2002). In addition, production of type I IFNs by
dsRNA is possibly regulated by PKR (Diebold et al.,
2003; Yang et al., 1995). However, a report showed that
the amount of type I IFN induced by NDV was not al-
tered in PKR−/− MEFs (Smith et al., 2001). Since induc-
tion of IFN-β after NDV, VSV, and SV is solely dependent
on RIG-I in MEFs, it is possible that RIG-I, but not PKR,
is a bona fide cytoplasmic receptor for the recognition
of RNA viruses.
Analysis of signaling pathways revealed that RIG-I is
indispensable for the activation of both IRF3 and NF-
κB in response to viral infection and that TBK1 and
IKK-i are activated downstream of RIG-I to trigger IFN
response. TBK1 and IKK-i are essential for the induc-
tion of type I IFNs in TLR4 signaling, indicating that
both the RIG-I and TLR signaling pathways converge
to TBK1/IKK-i to activate IRF3. Given that TBK1 and
IKK-i are dispensable for NF-κB activation, RIG-I
should control a signaling pathway leading to NF-κB in
addition to the TBK1/IKK-i/IRF3 pathway (Fitzgerald et
al., 2003; Sharma et al., 2003; McWhirter et al., 2004;
Hemmi et al., 2004). It is interesting to explore the
mechanism of how RIG-I signals to activate NF-κB.
Although many cell types produce type I IFNs, DCs
are known to be a potent inducer of type I IFNs after
viral infection. Among subsets of DCs, pDCs are iden-
tified as the major source of type I IFNs in vivo after
viral infection. However, depletion experiments re-
vealed that pDCs are not essential for type I IFN re-
sponse to lymphocytic choriomeningitis virus, and con-
ventional DCs are still a candidate for a type I IFN
inducer (Dalod et al., 2002). First, analysis of cDCs from
RIG-I−/− mice revealed that RIG-I plays an essential role
in type I IFNs and IL-6 production in the cells. However,
−/−cDCs were infected with NDV for 24 hr. IFN-α production from pDCs (2 ×
Data are shown as mean ± SD of triplicate samples of a representative froIFN-α in response to NDV infection. By contrast, the
TLR system plays an important role in pDCs, but not in
cDCs, suggesting that pDCs have a specific and elabo-
rate mechanism to produce IFN-α. Of note, although
the amount of IFN-α mRNA induced was severely im-
paired, the induction of IFN-α in Flt3L-cultured pDCs
from MyD88−/− mice was not completely abrogated.
These suggest that a pathway(s) other than TLRs also
contributes to virus-induced IFN response to some ex-
tent. It is possible that RIG-I marginally plays a role in
type I IFN production even in pDCs.
Analysis of pDCs deficient in each TLR revealed that
TLR7 mainly plays an important role in NDV recognition,
although TLR9 also partially participates in this pro-
cess. Since TLR7 recognizes viral single-stranded RNA
and is expressed in endosomal membranes (Lee et al.,
2003; Heil et al., 2003), pDCs may sense the presence
of ss RNA of NDV by endosomal uptake of its virions.
In contrast, cDCs and fibroblasts may recognize
viruses only after the invasion into the cytoplasm. Fur-
ther study will also be needed to clarify the functional
difference between the two types of type I IFN induc-
tion systems in in vivo viral infection.
Experimental Procedures
Generation of RIG-I-Deficient Mice
The RIG-I gene was isolated from genomic DNA extracted from
ES cells (GSI-I) by PCR. The targeting vector was constructed by
replacing a 3.6 kb fragment encoding the RIG-I ORF (exons 8–10)
with a neomycin-resistance gene cassette (neo), and a herpes sim-
plex virus thymidine kinase (HSV-TK) driven by PGK promoter was
inserted into the genomic fragment for negative selection. After the
targeting vector was transfected into ES cells, G418 and gan-
cyclovir doubly resistant colonies were selected and screened by
PCR and further confirmed by Southern blotting. Homologous re-
combinants were microinjected into C57BL/6 female mice, and het-
erozygous F1 progenies were intercrossed in order to obtain RIG-
I−/− mice.
Mice, Cells, Virus, and Reagents
MyD88−/− (Adachi et al., 1998), TLR7−/− (Hemmi et al., 2002), TLR9−/−
(Hemmi et al., 2000), and MyD88−/−TRIF−/− (Yamamoto et al., 2003)
mice were as described. TNF-α −/− mice were kindly provided by
K. Sekikawa (Tagawa et al., 1997). TBK1−/−IKK-i−/− MEFs were as
described (Hemmi et al., 2004). RIG-I−/− MEFs were prepared from
day 12.5–13.5 embryos. Lung fibroblasts and bone marrow cells
were prepared from 1- to 2-week-old RIG-I−/− mice. Recombinant
vesicular stomatitis virus (VSV) was a gift from T. Abe and Y. Matsu-
ura (Osaka University). Sendai virus (SV) Z strain was provided by10 ) or cDCs (2 × 10 ) was measured by ELISA.
m two independent experiments.
Immunity
26595 was purchased from Sigma-Aldrich. Poly (I:C) was purchased P
Tfrom Amersham Biosciences. Polyclonal anti-IRF3 antibody was
raised as described (Yamamoto et al., 2003). Polyclonal anti-RIG-I p
antibody was raised against amino acids 907–920 of mouse RIG-I. m
As IFN-β pretreatment, 1000 U/ml IFN-β was used 15 hr before VSV m
infection. Synthesized oligodeoxynucleotides were purchased from (
Hokkaido System Science. The sequences and backbones of oli- c
godeoxynucleotides (ODN) are as described (Hemmi et al., 2003); C




2Total RNA from MEFs was extracted using TRIzol reagent (Invitro-
sgen), electrophoresed, transferred to nylon membranes, and then
nhybridized with an indicated cDNA probe. To detect the expression
mof RIG-I mRNA, a 400 bp fragment (exons 5–8) containing DExD/H
box domain was used as a probe. The same membrane was rehy-
abridized with a β-actin probe.
c
(
Western Blot Analysis T
MEFs were transfected with 10 g/ml poly (I:C) for 8 hr. The cells
were then lysed in a lysis buffer containing 1.0% Nonidet-P40, 150
mM NaCl, 20 mM Tris-Cl (pH 7.5), 1 mM EDTA, and protease inhibi- Q
tor cocktail (Roche). The cell lysates were dissolved by SDS-PAGE F
and transferred onto a PVDF membrane. The membrane was blot- t
ted with the specific antibody to the indicated protein, and visual- (




fFor histological analysis, fetuses derived at 12.5 days postcoitum
cwere fixed with 3.7% formaldehyde. Transverse sections through
pthe fetal liver (5 m) were cut and stained with hematoxylin and
6eosin.
Plaque Assay M
Culture supernatants were collected from MEFs infected with VSV. F
Virus yield in culture supernatants was determined by standard s
plaque assay. Prepared BHK cells were infected with serial dilu- t
tions of the recovered viruses. The cells were overlaid with DMEM e
containing 1% low melting agarose and incubated for 24 hr. Then I
plaques were counted. a
Electrophoretic Mobility Shift Assay
FMEFs (1 × 106) were stimulated with 10 g/ml LPS or infected with
FNDV for the indicated periods. Nuclear extracts were purified from
ocells using lysis buffer (10 mM HEPES-KOH [pH 7.8], 10 mM KCl,
a10 mM EDTA [pH 8.0]), and then incubated with a specific probe
afor ISRE or NF-κB DNA binding sites, electrophoresed, and visual-
uized by autoradiography (Yamamoto et al., 2003).
c
L
Native PAGE Assay I
MEFs (1 × 106) were infected with NDV for the indicated periods s
and then lysed. The cell lysates in native PAGE sample buffer (62.5 (
mM Tris-Cl [pH 6.8], 15% glycerol, and 1% deoxycholate) were
separated on a native PAGE and then immunoblotted with anti-
IRF3 antibody (Yamamoto et al., 2003).
S
SLuciferase Assay
iMammalian expression plasmid for mouse RIG-I was constructed
in the pEF-BOS. The cDNA fragment encoding the ORF of RIG-I
was amplified by RT-PCR from a total RNA prepared from mouse
Alung fibroblasts. MEFs obtained from wild-type, RIG-I−/−, or TBK1−/−
IKK-i−/− mice were transiently transfected with reporter constructs
Wcontaining the IFN-β promoter together with the empty vector (con-
Strol), RIG-I, or TBK-I and IKK-i expression vector. As an internal, a
mRenilla luciferase construct was transfected. Transfected cells were
Mmock treated (mock) or infected with SV (moi = 20) for 24 hr, lysed,
Oand subjected to the luciferase assay using a dual-luciferase repor-
ter assay system (Promega) treparation of Dendritic Cells
o prepare in vitro bone marrow DCs, bone marrow cells were pre-
ared from femora and tibia. Then cells were cultured in RPMI 1640
edium supplemented with 10% FCS, 100 M 2-ME, and 100 ng/
l human Flt3 ligand (PeproTech) or 10 ng/ml murine GM-CSF
PeproTech) (Hemmi et al., 2003). After 6–8 days, the cells were
ollected and used as Flt3L-induced BMDCs (Flt3L-DCs) or GM-
SF-induced BMDCs (GM-CSF-DCs), respectively. In the case of
ulturing GM-CSF-DCs, medium was changed every 2 days. To
repare splenocytes containing DCs, spleens were cut unto small
ragments and incubated with RPMI 1640 medium containing 400
/ml collagenase (Wako) and 15 g/ml DNase (Sigma) at 37°C for
0 min. For the last 5 min, 5 mM EDTA was added. Single cell
uspensions were prepared after RBC lysis and subjected to the
egative selection of T and B cells using Thy1.2 and anti-CD19
icrobeads (Miltenyi).
Cells purified from negative selection were used for splenic pDCs
nd cDCs. To prepare splenic pDCs and cDCs, CD11c+mPDCA-1+
ells and CD11chighmPDCA-1− cells were sorted by FACS Vantage
BD bioscience) and used as splenic pDCs and cDCs, respectively.
he purity of sorted cells was 97%–99% (data not shown).
uantitative Real-Time PCR
or Q-PCR, RNA from GM-CSF-DCs infected with NDV was quanti-
ated, and 1 g of RNA was reverse-transcribed using Superscript2
Invitrogen) according to the manufacturer’s instructions, with ran-
om hexamers as primers. Q-PCR analysis was done using the
700 Sequence Detector (Applied Biosystem). Q-PCR was con-
ucted in a final volume of 25 l containing cDNA amplified as
escribed before, 2× PCR Master Mix (Applied Biosystem), and the
ollowing primers: 18s rRNA (Applied Biosystem) as an internal
ontrol, IFN-α4, IFN-α6/8, IFN-β, and IL-6 (Assay on Demand). Am-
lification conditions were: 95°C (10 min), 35 cycles of 95°C (15 s),
0°C (60 s), 50°C (120 s).
easurement of IFN- and IL-6 Production
lt3L-DCs (2 × 105) were infected NDV or stimulated with 3 M
ynthesized oligodeoxynucleotides, D35 for 24 hr. Culture superna-
ants were collected and analyzed for IFN-α or IL-6 production with
nzyme-linked immunosorbent assay (ELISA). ELISA kits for mouse
FN-α and IL-6 were purchased from PBL Biomedical Laboratories
nd R&D Systems, respectively.
low Cytometry
or intracellular IFN-α staining, Flt3L-DCs were treated with NDV
r 2 M D19 for 4.5 hr. Golgi stop (BD PharMingen) was added for
n additional 3.5 hr, and cells were collected and fixed in paraform-
ldehyde. Staining was performed in saponin-containing buffer
sing a mixture of rat anti-mouse IFN-α antibodies (clone F18, Hy-
ult Biotechnology b.v. and clone RMMA-1, PBL Biomedical
aboratories), followed by biotinylated mouse anti-rat IgG (Jackson
mmunoResearch), and Streptavidin-APC (PharMingen). Cells were
ubsequently stained with CD11c-FITC (clone HL3) and B220-PE
clone RA3-6B2) and analyzed on a FACS Calibur (BD Bioscience).
upplemental Data
upplemental Data are available for this article at http://www.
mmunity.com/cgi/content/full/23/1/19/DC1/.
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